Abstract
https://www.abstractsonline.com/pp8/#!/10517/presentation/20263
3 products
3 drugs
1 indication
2 targets
Indication
MelanomaProduct
ipilimumab/nivolumabProduct
IpilimumabProduct
NivolumabDrug
ipilimumabDrug
nivolumabTarget
CTLA-4 (ipilimumab)Target
PD-1